SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 10-Q

     [X]  Quarterly  Report  Pursuant  to Section 13 or 15(d) of the  Securities
          Exchange Act of 1934 FOR THE QUARTERLY PERIOD ENDED November 30, 2001

                                       OR

         Transition Report Pursuant to Section 13 or 15(d) of the Securities
         Exchange Act of 1934 from the transition period from ____ to _____

                          Commission File Number 0-9987


                            GLOBUS GROWTH GROUP, INC.
             (Exact name of registrant as specified in its charter)



          New York                                             13-2949462
   (State or other jurisdiction of                          (I.R.S. Employer
   incorporation or organization)                          Identification No.)


   44 West 24th Street, New York, NY                               10010
   (Address of principal executive offices)                     (zip code)


                                 (212) 243-1000
              (Registrant's telephone number, including area code)




     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days. Yes [X]     No [ ]

                APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
                   PROCEEDINGS DURING THE PRECEDING FIVE YEARS

     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by Section 12, 13 or 15(d) of the  Securities  Exchange Act
of 1934 subsequent to the distribution of securities under a plan confirmed by a
court. Yes [ ] No [ ]



                      APPLICABLE ONLY TO CORPORATE ISSUERS:

     Indicate the number of shares  outstanding of each of the issuer's  classes
of common stock, as the latest  practicable date:  2,499,000  (including 151,743
held in treasury)


<PAGE>

PART I - FINANCIAL INFORMATION
Item 1.  Financial Statements

GLOBUS GROWTH GROUP, INC.

CONDENSED BALANCE SHEETS

<TABLE>
<CAPTION>
                                                                                 November 30,    February 28,
                                                                                     2001            2001
                                                                                  ----------     ----------

ASSETS                                                                           (Unaudited)    (See Note 1)
<S>                                                                               <C>            <C>
     Cash                                                                                 $0        $21,000
     Investments in Securities (Note 3)                                           $1,279,000     $1,387,000
     Other Assets                                                                    $14,000        $11,000
                                                                                  ----------     ----------
     TOTAL                                                                        $1,293,000     $1,419,000
                                                                                  ----------     ----------




     LIABILITIES AND STOCKHOLDERS'  EQUITY

     Liabilities
       Accounts payable and accrued expenses                                      $1,352,000     $1,282,000
       Loans payable to officers/shareholders                                       $396,000       $326,000
       Demand loan payable to related party                                         $336,000       $329,000
                                                                                  ----------     ----------
     Total Liabilities                                                            $2,084,000     $1,937,000
                                                                                  ----------     ----------


     Stockholders' equity (Note 2)
     Preferred stock - $.10 par value, Authorized - 450,000 shares
          None Issued
     Series B convertible preferred stock - $.10 par value
          Authorized - 50,000 shares, None issued
     Common stock - $.01 par value, Authorized - 4,500,000
          shares, Issued 2,499,000 shares at 11/30/01                                $25,000        $25,000
     Additional paid in capital                                                   $2,747,000     $2,747,000
     Treasury Stock, 151,743 shares at 11/30/01                                     ($41,000)      ($41,000)
     Accumulated deficit                                                         ($3,522,000)   ($3,249,000)
                                                                                  ----------     ----------
     Total stockholders' deficiency                                                ($791,000)     ($518,000)
                                                                                  ----------     ----------
     TOTAL                                                                        $1,293,000     $1,419,000
                                                                                  ----------     ----------




     (See Accompanying Notes to Financial Statements)

</TABLE>
<PAGE>

GLOBUS GROWTH GROUP, INC.

STATEMENT OF OPERATIONS

     (Unaudited)

<TABLE>
<CAPTION>

                                                                             Three Months                Nine Months
                                                                          Ended November 30,          Ended November 30,
                                                                         2001            2000          2001         2000
                                                                       ---------      ---------      ---------    ---------
<S>                                                                      <C>           <C>            <C>          <C>
     Gain (loss) on investments:
        Realized                                                         $1,000        $17,000        $14,000      $37,000
        Unrealized                                                       $4,000      ($165,000)      ($63,000)   ($451,000)
                                                                       ---------      ---------      ---------    ---------
     Total                                                               $5,000      ($148,000)      ($49,000)   ($414,000)
     Dividend Income                                                         $0             $0             $0       $1,000
     Interest Income                                                         $0                            $0
     Consulting and other income                                             $0        $10,000        $26,000      $19,000
                                                                       ---------      ---------      ---------    ---------
     TOTAL                                                               $5,000      ($138,000)      ($23,000)   ($394,000)

     Expenses:
        General and administrative                                      $72,000        $73,000       $230,000     $209,000
        Interest                                                         $6,000         $4,000        $16,000      $11,000
                                                                       ---------      ---------      ---------    ---------
     TOTAL                                                              $78,000        $77,000       $246,000     $220,000

     Income (loss) from operations before taxes                        ($73,000)     ($215,000)     ($269,000)   ($614,000)
     (Benefit)/Provision for taxes                                           $0             $0             $0           $0
                                                                       ---------      ---------      ---------    ---------
     Net Income (Loss)                                                 ($73,000)     ($215,000)     ($269,000)   ($614,000)
                                                                       ---------      ---------      ---------    ---------


     Net Income (Loss) per share of common
         stock - basic and diluted                                       ($0.03)        ($0.09)        ($0.11)      ($0.26)
     Weighted Average Number of shares of
         Stock Outstanding - basic and diluted                        2,347,257      2,347,257      2,347,257    2,347,257
                                                                      ---------      ---------      ---------    ---------

     (See Accompanying Notes to Financial Statements)

</TABLE>
<PAGE>

GLOBUS GROWTH GROUP, INC.

STATEMENTS OF CASH FLOWS
            (Unaudited)

<TABLE>
<CAPTION>
                                                                                                              Nine Months
                                                                                                          Ended November 30,
                                                                                                       2001                   2000
                                                                                                    -----------            ---------
CASH FLOWS FROM OPERATING ACTIVITIES:
<S>                                                                                                  <C>                  <C>
        Net Loss                                                                                     ($269,000)           ($614,000)
        Adjustments to reconcile net loss to net cash used in
                operating activities:
                Realized (gain) on investments                                                        ($14,000)            ($37,000)
                Unrealized loss on investments                                                         $63,000             $451,000
                Increase in accounts payable, accrued expenses and
                    accrued interest on loans                                                          $82,000              $70,000
                (Increase) decrease in prepaid assets                                                  ($4,000)             ($2,000)
                                                                                                     ----------           ----------
                Net cash used in operating activities                                                ($142,000)           ($132,000)
                --------------------------------------------------------------------------------------------------------------------

CASH FLOWS FROM INVESTING ACTIVITIES:
        Purchase of investments                                                                             $0             ($25,000)
        Proceeds from sale of investments                                                              $59,000              $53,000
                                                                                                     ----------           ----------
                Net cash provided by investing activities                                              $59,000              $28,000
                --------------------------------------------------------------------------------------------------------------------

CASH FLOWS FROM FINANCING ACTIVITIES:
        Repayment of loans payable to officers/shareholders                                                 $0              ($5,000)
        Increase in loans payable to officers/shareholders                                             $62,000              $53,000
                                                                                                     ----------           ----------
                Net cash provided by financing activities                                              $62,000              $48,000
                --------------------------------------------------------------------------------------------------------------------

Net increase (decrease) in cash                                                                       ($21,000)            ($56,000)

Cash - beginning of period                                                                             $21,000              $58,000

Cash - end of period                                                                                        $0               $2,000

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
        Cash paid during the period for:
                Interest                                                                                    $0                   $0
                Income Taxes                                                                                $0                   $0

(See Accompanying Notes to Financial Statements)

</TABLE>
<PAGE>

GLOBUS GROWTH GROUP, INC.  Notes to Condensed Financial Statements  November 30,
                                                                           2001

                                   (Unaudited)


     Note 1 -  Basis of Condensed Information

               In  the  opinion  of  the  Company,  the  accompanying  unaudited
               condensed   financial   statements   contain   all   adjustments,
               consisting  of  only  normal  recurring  accruals,  necessary  to
               present  fairly the  financial  position as of November 30, 2001,
               the results of  operations  for the three and nine  months  ended
               November 30, 2001 and 2000,  and statements of cash flows for the
               nine months ended November 30, 2001 and 2000.

               The results of operations  for the nine months ended November 30,
               2001 are not necessarily indicative of the results to be expected
               for the full year.

               Certain  information and note  disclosures  normally  included in
               financial  statements  prepared  in  accordance  with  accounting
               principles  generally  accepted  in the United  States of America
               have  been  condensed  or  omitted.   These  condensed  financial
               statements  should  be read in  conjunction  with  the  financial
               statements  and notes thereto  included in the  Company's  annual
               report filed on Form 10-K for the year ended February 28, 2001.

               The balance  sheet at February 28, 2001 has been derived from the
               Company's  audited balance sheet included in its Annual Report on
               Form 10-K.



     Note 2 -  Earnings Per Share

               Per share data are based on the weighted average number of common
               shares outstanding during the period.



     Note 3 -  Investments

               As of February 28, 2001 and November  30, 2001,  investments  are
               carried at fair value, which, for readily marketable  securities,
               represents  the last  reported  sales  price or bid  price on the
               valuation   date.   Investments  in  restricted   securities  and
               securities  which are not readily  marketable are carried at fair
               value as determined in good faith by  Management,  in the case of
               interim financial statements,  and by the Board of Directors,  in
               the case of year end financial  statements;  in each instance, in
               the  exercise of their  respective  judgments,  after taking into
               consideration various indications of value available to them.

                     (Continued on next page)
<PAGE>
GLOBUS GROWTH GROUP, INC.  Notes to Condensed Financial Statements  November 30,
                                                                           2001

                                   (Unaudited)

Note 3 - (Continued)

<TABLE>
<CAPTION>

                                                        November 30,                            February 28,
                                                            2001                                    2001
                                                            ----                                    ----

                                                No.                                     No.
                                              Shares       Value         Cost         Shares    Value       Cost
                                              ------       -----         ----         ------    -----       ----
<S>                                            <C>         <C>          <C>           <C>       <C>        <C>
     Common Stock
     Carta Proteomics, Inc.                    33,333      $13,000      $13,000       33,333    $13,000    $13,000
     Catamount Brewing Co.                     23,215                  $176,000       23,215              $176,000
     Repligen Corporation                       6,968      $17,000      $13,000       30,718   $124,000    $58,000
     Tumbleweed Communications Corp.              204       $1,000       $7,000          204     $1,000     $7,000
     ValiGen, N. V                             85,403     $444,000     $444,000       85,403   $444,000   $444,000
                                                        ----------   ----------              ---------- ----------

     Total Common Stock                                   $475,000     $653,000                $582,000   $698,000
                                                        ----------   ----------              ---------- ----------
     Preferred Stock
     Carta Proteomics, Inc. Series A Pfd      100,000     $150,000     $150,000      100,000   $150,000   $150,000
     Carta Proteomics, Inc. Series B Pfd       10,000      $25,000      $25,000       10,000    $25,000    $25,000
     Catamount Brewing Co. Pfd                  4,286                  $150,000        4,286              $150,000
     Genitope Corp. Series A Pfd              420,858     $210,000     $210,000      420,858   $210,000   $210,000
     Genitope Corp. Series B Pfd              332,992     $420,000     $420,000      332,992   $420,000   $420,000
                                                        ----------   ----------              ---------- ----------

     Total Preferred Stock                                $805,000     $955,000                $805,000   $955,000
                                                        ----------   ----------              ---------- ----------
     Total Investments - Fair  value                    $1,280,000   $1,608,000              $1,387,000 $1,653,000
                                                        ----------   ----------              ---------- ----------

</TABLE>
<PAGE>

Item 2.  Management's  Discussion  and Analysis of Financial  Condition and
         Results of Operations

Results of Operations

     Prior to fiscal 1987, the Company was engaged in the camera and photography
business.  On February 28, 1986,  the Company sold its operating  business to an
affiliated company and since that date the Company's principal activity has been
the making of investments in other companies.

     At November 30, 2001,  the Company had total assets of $1,293,000  compared
to total assets of  $1,419,000  at February  28, 2001.  Included in total assets
were  investments  of $1,279,000 at November 30, 2001 and $1,387,000 at February
28,  2001.  Shareholders  deficiency  was  ($791,000)  at November  30, 2001 and
($518,000) at February 28, 2001.  Loss on investments  amounted to ($49,000) for
the nine month period ended November 30, 2001,  compared to a loss of ($414,000)
for the nine month period ended November 30, 2000.  Included in such losses were
realized  gain of $14,000 and  unrealized  loss of ($63,000)  for the nine month
period  ended  November  30,  2001  compared  to  realized  gain of $37,000  and
unrealized loss of ($451,000) for the nine month period ended November 30, 2000.
Total gain on  investments  for the three month period  ended  November 30, 2001
amounted to $5,000,  compared to a loss of ($148,000) for the three month period
ended November 30, 2000. Included in such gains and losses were realized gain of
$1,000 and  unrealized  gain of $4,000 for the three month period ended November
30, 2001 compared to realized gain of $17,000 and unrealized  loss of ($165,000)
for the three month period  ended  November 30,  2000.  The  unrealized  loss of
($63,000) in the 2001 nine month period and the unrealized loss of ($451,000) in
the 2000 nine month period was principally due to the decline in market value of
the common stock owned in Repligen  Corporation.  Operating expenses,  including
interest  charges,  amounted  to  $246,000  for the 2001 nine  month  period and
$220,000 for the 2000 nine month period. Operating expenses,  including interest
charges,  amounted to $78,000 for the three months  ended  November 30, 2001 and
$77,000 for the three months ended November 30, 2000. Loss from operations, both
before and after  provision for taxes,  was ($269,000) for the nine month period
ended  November 30, 2001 compared to ($614,000)  for the nine month period ended
November 30, 2000.  Loss from  operations,  both before and after  provision for
taxes, was ($73,000) for the three month period ended November 30, 2001 compared
to loss of ($215,000)  for the three month period ended  November 30, 2000.  Net
(loss) per share was ($0.11) for the 2001 nine month period  compared to ($0.26)
for the comparable 2000 nine month period.  Net (loss) per share was ($0.03) for
the three  months  ended  November  30,  2001  compared to net loss per share of
($0.09) for the three months  ended  November  30,  2000.  The weighted  average
number of shares of Common Stock  outstanding  at November 30, 2001 and November
30, 2000 is 2,347,257.

     In the nine months  ended  November  30,  2001,  23,750  shares of Repligen
Corporation  have been sold for total sales proceeds of  approximately  $59,000,
including  12,000 shares being sold in the three months ended  November 30, 2001
for total sales proceeds of approximately  $31,000.  These proceeds were used to
pay  operating  expenses.  The fair market value of the common stock of Repligen
Corporation has declined from approximately $4 per share at February 28, 2001 to
approximately $2 per share at November 30, 2001.

     As of February 28, 2001 and November 30, 2001,  investments  are carried at
fair  value,  which,  for readily  marketable  securities,  represents  the last
reported  sales  price  or bid  price  on the  valuation  date.  Investments  in
restricted  securities  and  securities  which are not  readily  marketable  are
carried at fair value as determined in good faith by Management,  in the case of
interim financial statements, and by the Board of Directors, in the case of year
end financial statements;  in each instance, in the exercise of their respective
judgments,   after  taking  into  consideration  various  indications  of  value
available to them.  There have been no changes in the valuation of the privately
held portfolio companies.

<PAGE>

Liquidity, Capital Resources and Other Matters Affecting Financial Condition

     The near term  liquidity of the  Company,  as well as its near term capital
resources position, are presently dependent upon the continued  willingness,  as
to which  there can be no  assurance  whatsoever,  of the  members of the Globus
family who have made loans to the Company  not to demand  full or  substantially
full  repayment of such loans and to continue to make loans to the  Company,  if
necessary.  Thus, loans payable by the Company,  including accrued interest,  to
Mr. Stephen E. Globus (his individual  account) amounted to $215,000 at November
30, 2001, an increase of $1,000 from February 28, 2001. Loans payable to Messrs.
Stephen E. and Richard D. Globus (a separate joint account),  including  accrued
interest, amounted to $180,000 at November 30, 2001, an increase of $69,000 from
$111,000 at February 28, 2001. This increase was due to an increase in principal
of $62,000,  and an increase in accrued interest of approximately  $8,000. As at
November 30, 2001, loans payable to another member of the Globus family, to wit:
Ms. Jane Globus  (the mother of Stephen E. and Richard D.  Globus),  amounted to
approximately  $336,000,  including accrued  interest.  As at November 30, 2001,
unpaid  salary owing to Mr.  Stephen E. Globus was  $666,000,  and unpaid salary
owing to Mr.  Richard D. Globus was $635,000;  so that at such date the total of
monies owed to Messrs.  Stephen E. Globus, Richard D. Globus and Ms. Jane Globus
aggregated approximately $2,032,000.

     There are in fact presently no known events that can be considered  certain
to occur which would  materially  change favorably either the short term or long
term liquidity  (i.e.,  ability of the Company to generate  adequate  amounts of
cash to meet its needs for cash) or capital resources position (i.e.,  source of
funds) of the Company from that in which it presently finds itself,  and, absent
continuation  of the  presently  existing  loans  without call for  payment,  or
additional  loans,  from the Globus  family,  the present  liquidity and capital
resources  position of the Company  necessarily  adversely affects the financial
condition  of the  Company  and its  ability  to make new  investments.  In such
connection it must be noted that: the  profitability of a BDC, like the Company,
is largely  dependent upon its ability to make investments and upon increases in
the value of its  investments;  and a BDC is also  subject  to a number of risks
which are not generally present in an operating company, and which are discussed
generally  in Item 1 of the  Company's  10K  Report  for its  fiscal  year ended
February  28, 2001 to which Item  reference  is hereby  made.  Reference is also
hereby made to Item 1 and Item 7 of such Report and to the Financial  Statements
and notes  thereto  contained  in such  Report for  information  concerning  the
Company's investments and its financial condition.

     With  respect to its future  operations,  the  Company  has been  examining
various  alternatives  relating  to reducing  its  operating  expenditures.  The
Company's principal  operating  expenditures are related to its public reporting
requirements.  Previously, during calendar 2001, the Company had filed materials
with the United States Securities and Exchange Commission relating to a proposed
stock split transaction.  The Company is proposing, as of this date, to withdraw
such filing,  and will be pursuing other  alternatives with the SEC in an effort
to reduce its expenditures and, ultimately, to wind up its business.



Item 3. Quantitative and Qualitative Disclosures About Market Risk

        Not Applicable.

<PAGE>

PART II - Other Information

Item 6.  Exhibits and Reports on Form 8-K

         (a)   Reports on Form 8-K

               No  reports on Form 8-K have been filed  during the  quarter  for
               which this Report is filed.

<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


Date: January 17, 2002



                                                       GLOBUS GROWTH GROUP, INC.
                                                                    (Registrant)




                                                               STEPHEN E. GLOBUS
                                                          Chairman of the Board,
                                                   (Principal Executive Officer)




                                                                   LISA VISLOCKY
                                         Vice President, Chief Financial Officer